• About
    • Company Overview
    • Management Team
    • Board of Directors
    • Science Advisors
    • Neurology Advisors
    • Ophthalmology Advisors
    • Contacts
  • Science
    • Publications
    • Collaborators
  • Pipeline
    • Infantile Neuroaxonal Dystrophy (INAD)
    • Friedreich’s Ataxia (FA)
    • Amyotrophic Lateral Sclerosis (ALS)
    • Progressive Supranuclear Palsy (PSP)
    • Dry AMD
    • Future Targets
  • Patient Resources
    • Expanded Access Policy
    • Clinical Trials
    • Additional Resources
  • News & Events
    • Press Releases
    • News
    • Events
    • Videos
  • Careers
HomeNeurology AdvisorsCharles Stacey, MBBS, MRCS, MBA

Charles Stacey, MBBS, MRCS, MBA

Dr. Stacey is president and chief executive officer of Cerecin, a clinical-stage biotechnology company developing a platform of ketogenic compounds to treat neurological diseases.  Prior to joining Cerecin, he was with Inventages, a global life science venture capital group, with $1.5 billion under management. At Inventages, he focused on investments in neurology.

Before his tenure with Inventages, Dr. Stacey ran a medical device company and worked for a number of early-stage healthcare companies. He currently serves on the board of governors of the Accreditation Council for Medical Affairs (ACMA).

He received his medical degree from King’s College London and practiced as a trauma and reconstructive surgeon. Dr. Stacey completed an MBA at the London Business School and the Wharton School.  His original undergraduate degree and research were in neuroscience at UCL/Queen Square.

About
Science
  • Publications
Pipeline
  • Clinical
  • Preclinical
  • Future Targets
Patient Resources
  • Expanded Access Policy
News & Events
Careers
RETROTOPE, 4300 EL CAMINO REAL, SUITE 201, LOS ALTOS, CA 94022
Copyright ©️ 2015-2021 Retrotope Inc.
You are leaving Retrotope’s website. Retrotope does not guarantee the accuracy or completeness of the information contained on any third-party sites, nor does it endorse any of the opinions or information contained on those sites. Please click CONFIRM to continue. CONFIRM